Refine the list (min. 2 characters)
Keynote Presentation (In-Person)
Title: Postural orthostatic tachycardia syndrome (POTS)
Background: Postural Orthostatic Tachycardia Syndrome (POTS) is a complex and heterogeneous autonomic nervous system disorder characterised by orthostatic intolerance. Key diagnostic criteria include a sustained increase in heart rate of ≥30 bpm (or ≥40 bpm in children/adol [....] » Read More
Keynote Presentation (In-Person)
Cell-based therapy holds great potential to address unmet medical needs and revolutionize the healthcare bioindustry, as demonstrated by CAR-T cell therapy and stem cell transplantation, and has been considered as a promising option in the treatment of ischemic heart disease. The [....] » Read More
Keynote Presentation (In-Person)
Title: Post-translational modifications of proteins in cardiovascular diseases
Protein post-translational modifications, particularly reversible lysine acylation, have emerged as critical arbiters of cardiac homeostasis and disease. Our group has systematically employed quantitative PTM proteomics to elucidate the roles of propionylation, crotonylation, and [....] » Read More
Oral Presentation (In-Person)
Title: Cardiovascular alterations and clinical consequences of covid-19 infection
In addition to the typical pulmonary complications, COVID-19 infection is associated in 5%–20% of cases with cardiac abnormalities consistent with acute myocardial injury, which worsen the clinical course and prognosis of affected patients, including increased need for inte [....] » Read More
Oral Presentation (In-Person)
Title: The phlebectic crown: The importance of treatment
Background: Corona phlebectatica, also known as corona paraplantaris, is a recognized cutaneous manifestation of chronic venous insufficiency (CVI). It is characterized by dilated perimalleolar veins, blue and red telangiectasias, and capillary stasis. This clinical sign has been [....] » Read More
Oral Presentation (In-Person)
Title: Cardiovascular efficacy of GLP-1 receptor agonists: A systematic review and meta-analysis
Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have progressed from glucose-lowering agents to established cardioprotective therapies, with an unusually large and rapidly growing base of completed, adjudicated cardiovascular outcome trials (CVOTs). Objective [....] » Read More
Oral Presentation (In-Person)
Title: Chronic kidney disease: Looking beyond diabetes
A “perilous Paradox” of our time…Some of the greatest human and economic burden is caused by one of the most treatable yet underdiagnosed conditions: chronic kidney disease. Our current practice is to diagnose too late, begin treatment too late, too conservativ [....] » Read More
Oral Presentation (In-Person)
Title: Ultrasonic mean cut off values of the inferior vena cava (IVC) Diameter in some body adipocities
Background: Dilatation of the inferior vena cava (IVC) is used as the ultrasonic diagnostic feature in patients suspected of congestive heart failure. The IVC diameter has being reported to vary among the various body mass indexes (BMI) and Body Shape Indexes (ABSI).Knowledge of [....] » Read More
Keynote Presentation (Virtual)
Title: Vulnerable plaque stabilization with OMT vs preventive PCI
Background: This study demonstrates the recent strategy utilized in the management of vulnerable coronary plaques, with a major focus on the fact that instead of severe narrowed coronary arteries, plaque rupture is the major reason behind various STEMI events and sudden cardiac d [....] » Read More
Keynote Presentation (Virtual)
Background: The rapid expansion of digital health data and advances in artificial intelligence (AI) and machine learning (ML) have created new opportunities for laboratory medicine. Cardiovascular diseases (CVDs), a leading cause of global mortality, particularly in populati [....] » Read More
Oral Presentation (Virtual)
Title: Behavioural signals before clinical thresholds: How AI Is rewriting early cardiovascular risk
Cardiovascular disease remains the leading cause of death worldwide, yet most patients are still identified only after they have crossed a clinical threshold: a hypertensive reading, an abnormal lipid panel, a stress test that finally turns positive. By the time these markers cro [....] » Read More
Oral Presentation (Virtual)
Title: Mechanical circulatory support and transplantation in adult congenital heart disease
As the adult population with congenital heart disease (ACHD) continues to grow due to the improved survival in pediatric cardiac surgery, heart failure in this group of patients has become an increasing problem in the last two decades. If the conservative treatment fails, m [....] » Read More
Oral Presentation (Virtual)
Background: Cannabis use is increasingly encountered in emergency care, yet its cardiovascular effects are often underrecognized when younger patients present with chest pain, palpitations, syncope, or neurologic symptoms. This review synthesized current evidence and developed a [....] » Read More
Oral Presentation (Virtual)
Background: A coronary artery calcium (CAC) score of zero is widely used to defer further cardiac testing, on the assumption that it reliably excludes clinically significant coronary artery disease (CAD). However, CAC detects only calcified plaque and cannot identify non-calcifie [....] » Read More
Oral Presentation (Virtual)
Title: Impact of metabolic syndrome on myocardial status in ICU patients
Background: Metabolic Syndrome (MetS) is a highly prevalent condition among patients with acute myocardial infarction (AMI) in the intensive care unit (ICU), yet its direct impact on inhospital outcomes remains a subject of debate. This systematic review aims to synthesize the cu [....] » Read More
Oral Presentation (Virtual)
Introduction: Globally, ischemic heart disease has become one of the leading causes of disability-adjusted life years (DALYs), ranking first among adults over the age of 50. Residual risk can be classified into three main domains, residual lipid risk: persists despite LDL-C contr [....] » Read More
Poster Presentation (Virtual)
Background: Chronic heart failure (CHF) is a major contributor to global morbidity and mortality, and its progression is frequently complicated by cardiorenal syndrome—a bidirectional pathological interaction between the heart and kidneys. Endothelial dysfunction plays a ce [....] » Read More
© 2026 Mathews International LLC. All rights reserved.
